2021. A randomized, parallel, open-label clinical study comparing the effectiveness and safety of apremilast with methotrexate in individuals with moderate to severe palm plantar psoriasis. Indo-American Journal of Life Sciences and Biotechnology. 18, 3 (Jul. 2021), 68–79.